Printer Friendly
The Free Library
14,506,614 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Sadra Medical Raises $9 Million In Series A Financing; Company Seeks to Transform Heart Valve Therapy with Innovative Technology.


SARATOGA, Calif. -- Sadra Medical, a privately-held, development-stage Silicon Valley firm dedicated to developing innovative new therapies for aortic valve aortic valve
n.
The valve between the left ventricle of the heart and the ascending aorta, consisting of three semilunar cusps.


Aortic valve 
 disease, has recently completed a $9M Series A round of funding. Pequot Ventures co-led the financing, along with the company's original seed investors Onset Ventures and Schroder Ventures.

"Our goal is to minimize the invasiveness of aortic valve surgery, thereby improving patient care and making valve replacement possible for patients who are too ill to undergo surgery," stated Amr Salahieh, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Sadra Medical. "We're very motivated by the support of such a high caliber group of investors."

Treatment of aortic valve disease remains a significant and growing unmet clinical need. As many as 3 million people in the U.S. have aortic stenosis aortic stenosis
n. Abbr. AS
Pathological narrowing of the orifice of the aortic valve.


Aortic stenosis
A stiffening of the artery which carries blood from the heart to the body.
; however, only a small percentage of those are treated with the current standard of care, open-heart surgery open-heart surgery

Any surgical procedure opening the heart and exposing one or more of its chambers, most often to repair valve disease or correct congenital heart malformations (see congenital heart disease).
 using cardiopulmonary bypass cardiopulmonary bypass
n.
A procedure to circulate and oxygenate the blood during heart surgery involving the diversion of blood from the heart and lungs through a heart-lung machine and the return of oxygenated blood to the aorta.
. By delivering a highly-effective aortic valve replacement Aortic valve replacement is a cardiac surgery procedure in which a patient's aortic valve is replaced by a different valve. The aortic valve can be affected by a range of diseases; the valve can either become leaky (aortic insufficiency / regurgitation) or partially blocked (aortic  that reduces the risks and morbidity associated with surgery, Sadra Medical seeks to provide a therapeutic option for patients who are not being treated today.

Sadra Medical was founded in 2003 by Amr Salahieh and some leading-edge cardiovascular clinicians. Board members include Salahieh, Leslie Bottorff of Onset Ventures, Juliet Bakker of Pequot Ventures, Charles Warden representing Schroder Ventures, and Fred Khosravi, CEO of AccessClosure.

About Pequot Ventures

Pequot Ventures is the direct equity investment arm of Pequot Capital Management, Inc., a leading asset management firm with over $5.5 billion of capital under management. Pequot Ventures was founded in 1996, has over $1.5 billion in capital under management and has invested in over 150 companies in the healthcare and technology sectors. The group has offices in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
, Menlo Park, Los Angeles, Wellesley, MA and Westport, CT. www.pequotventures.com

About Onset Ventures

ONSET Ventures is a 20-year-old venture capital firm specializing in early/seed stage information and medical technology-based startups. Based in Menlo Park, CA, ONSET has pioneered a shirt-sleeves style of active collaboration with entrepreneurs to conceive and develop successful new businesses. The firm has invested in over 100 companies, and has in excess of $500 million under management. www.onset.com

About Schroder Ventures

Schroder Ventures Life Sciences ('SVLS') is a life sciences focused venture capital firm with funds totaling $900M in capital. Schroder Ventures advised funds have invested in the life sciences industry since the early 1980s and, to date, have backed over 100 companies internationally. SVLS SVLS Sacramento Valley Live Steamers (Rancho Cordova, CA)  was established in 1993 and currently has offices in London, Boston, and San Francisco. www.svlifesciences.com
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 16, 2004
Words:422
Previous Article:Coeur D'Alene Mines Requests Wheaton Shareholders' List; Wheaton Announces Formation of Special Committee.
Next Article:Texas Children's Hospital Selects MedeFinance Revenue Cycle Management Solution; ATB Manager Provides Real-Time Business Intelligence on Key Drivers...



Related Articles
Scientists 'grow' replacement heart valves. (valves grown from patient's own heart cells)(Brief Article)
TISSUE VALVE GETS EUROPEAN AND CANADIAN APPROVALS.
TAKING IT DAY BY DAY; MOM'S RESOLVE KEY TO RAISING ILL SON.(NEWS)
Pulmonic valve endocarditis. (Case Report).
Between physics and metaphysics: Mulla Sadra on nature and motion.
Myocor, Inc. Announces Completion of $24 Million Series D Financing.
New Leaf Venture Partners Announces $3.5 Million Financing in Direct Flow Medical.
MiCardia Corporation Completes $9 Million Private Financing.
Sadra Medical Raises $19 Million in Series B Financing.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles